Incorporating T2Candida testing into rational antifungal (AF) management: A successful pilot study of diagnostic stewardship directed toward specific intensive care unit patients at-risk for sepsis due to invasive candidiasis
T2Candida (T2MR) versus Beta-D-Glucan for preemptive antifungals stewardship in the intensive care unit
Novel T2Candida Panel assay compared to blood cultures for detection of candidemia in transplant and non-transplant patients
Diagnosing candidemia with the T2Candida Panel: An instructive case of septic shock in which blood cultures were negative
T2Bacteria: Rapid and sensitive detection and identification of sepsis pathogens in whole blood specimens by T2MR®
T2Candida is more sensitive and rapid than blood culture for monitoring candidemia in patients with proven infection
Investigational study: T2MR® platelet analysis correlates with LTA and reveals unique details of ADP-mediated platelet activation in whole blood